These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19690211)

  • 21. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion.
    Deacon RM; Mooney-Somers J; Treloar C; Maher L
    Health Soc Care Community; 2013 Jul; 21(4):402-10. PubMed ID: 23465052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study.
    Tompkins CN; Wright NM; Jones L
    Br J Gen Pract; 2005 Apr; 55(513):263-8. PubMed ID: 15826432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social inclusion and hepatitis C: exploring new possibilities for prevention.
    Treloar C; Valentine K; Fraser S
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):397-404. PubMed ID: 21504397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring attitudes toward injecting drug users and people with hepatitis C.
    Brener L; von Hippel W
    Subst Use Misuse; 2008; 43(3-4):295-302. PubMed ID: 18365932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
    Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
    Scand J Infect Dis; 2009; 41(10):727-34. PubMed ID: 19688640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of hepatitis C in injection drug users.
    Edlin BR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S210-9. PubMed ID: 12407596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.
    Treloar C; Laybutt B; Jauncey M; van Beek I; Lodge M; Malpas G; Carruthers S
    Int J Drug Policy; 2008 Feb; 19(1):59-65. PubMed ID: 18312820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
    Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
    Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.
    Balogun MA; Murphy N; Nunn S; Grant A; Andrews NJ; Teo CG; Ramsay ME; Parry JV
    Epidemiol Infect; 2009 Jul; 137(7):980-7. PubMed ID: 19102796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.
    Jack K; Willott S; Manners J; Varnam MA; Thomson BJ
    Aliment Pharmacol Ther; 2009 Jan; 29(1):38-45. PubMed ID: 18945252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.